Sam Fazeli
speaker
906 appearances
5 recordings
1 series
first heard Oct 2025
last heard 31 Mar
Sam Fazeli’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 5 in all, peaking in Mar 2026 with 2.
Appearances
Okay, cool.
And then, of course, we've got the...
We had the rivulogostomic plus dato in tropion pantumar 03, which includes, we've got that coming, both first and second line.
And what's the plan on that now?
I mean, you know, first line to challenge EV Pembro, is that the idea or...?
So, Susan, we've...
eaten one hour of your time, which is much more valuable than mine, that's for sure.
And we didn't talk about non-small cell, we didn't talk about gastric, hepatocellular, I had all these things here, colorectal, ovarian, et cetera, of course.
But that's the problem with AstraZeneca.
You've got things in, fingers in all kinds of pies.
I just wanted to highlight, you did have some Artemido 1 data,
which I got excited by.
I did my maths in the comparison things, which of course is not head to head.
And then I'll go and take the sections of,
the keynote, was it 42-year patients and tried to make comparisons, which looked really good, I have to say, on small numbers of patients.
pbr1 expression uh is very encouraging obviously it's more data set but yes you can you can even in the um 1249 i was i was interested in i did i did a little comparison to keynote 42 by taking just the patients that had no prior therapy in your data set and that looked that looked from an orr perspective better um we'll see yeah again i think one of the things that we're seeing with um
Perhaps I should focus on the 10% plus or 20% plus or whatever.
We'll see, right?
Susan, it's exactly one hour.
Thank you very much for your time.
Showing 881–900 of 906 · page 45 of 46
← Previous
Next →